OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BioEssays (2020) Vol. 42, Iss. 5
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 155

YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Frank Szulzewsky, Eric C. Holland, Valeri Vasioukhin
Developmental Biology (2021) Vol. 475, pp. 205-221
Open Access | Times Cited: 113

Insights into recent findings and clinical application of YAP and TAZ in cancer
James Franklin, ZhengMing Wu, Kun‐Liang Guan
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 512-525
Closed Access | Times Cited: 110

Therapeutic targeting of TEAD transcription factors in cancer
Ajaybabu V. Pobbati, Ramesh Kumar, Brian P. Rubin, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 5, pp. 450-462
Closed Access | Times Cited: 81

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
Shigeto Nishikawa, Tomoo Iwakuma
Cancers (2023) Vol. 15, Iss. 2, pp. 429-429
Open Access | Times Cited: 64

Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Cancer Letters (2021) Vol. 507, pp. 112-123
Open Access | Times Cited: 83

Wnt and Src signals converge on YAP‐TEAD to drive intestinal regeneration
Oriane Guillermin, Nikolaos Angelis, Clara Sidor, et al.
The EMBO Journal (2021) Vol. 40, Iss. 13
Open Access | Times Cited: 67

Cell Signaling Pathways That Promote Radioresistance of Cancer Cells
Michel M. Ouellette, S. Zhou, Ying Yan
Diagnostics (2022) Vol. 12, Iss. 3, pp. 656-656
Open Access | Times Cited: 44

YAP antagonizes TEAD‐mediated AR signaling and prostate cancer growth
Xu Li, Shu Zhuo, Yong Suk Cho, et al.
The EMBO Journal (2023) Vol. 42, Iss. 4
Open Access | Times Cited: 25

WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth
Keshan Wang, Fen Ma, Seiji Arai, et al.
Cancer Research (2023) Vol. 83, Iss. 7, pp. 1016-1030
Open Access | Times Cited: 24

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Anna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
Hongge Liang, Yan Xu, Jing Zhao, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 652-666
Open Access | Times Cited: 13

A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion
Antoine Khalil, Daan Smits, Peter D. Haughton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
Subhadeep Das, Shayak Samaddar
Cancers (2025) Vol. 17, Iss. 2, pp. 255-255
Open Access | Times Cited: 1

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
Ping‐Chih Hsu, Cheng‐Ta Yang, David M. Jablons, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1361-1361
Open Access | Times Cited: 60

Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Aukie Hooglugt, Miesje M. van der Stoel, Reinier A. Boon, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 54

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
Laurence Pellerin, Lorry Carrié, Carine Dufau, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3147-3147
Open Access | Times Cited: 50

The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
Ángel Ortega, Ivana Vera, María Inés Díaz, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 430-430
Open Access | Times Cited: 44

Role of K63-linked ubiquitination in cancer
Liangzi Cao, Xiaofang Liu, Bowen Zheng, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 35

On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm
Arwen Conod, Marianna Silvano, Ariel Ruiz i Altaba
Cell Reports (2022) Vol. 38, Iss. 10, pp. 110490-110490
Open Access | Times Cited: 33

FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway
Jinyuan Huang, Jing Yang, Yudi Zhang, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 1, pp. 113585-113585
Closed Access | Times Cited: 21

Mechanotransduction in tumor dynamics modeling
Beatriz Blanco, Héctor Gómez, Juan Manuel Melchor Rodríguez, et al.
Physics of Life Reviews (2023) Vol. 44, pp. 279-301
Open Access | Times Cited: 18

Phase separation of Hippo signalling complexes
Teresa Bonello, Danfeng Cai, Georgina Fletcher, et al.
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 17

Imperfect wound healing sets the stage for chronic diseases
Paul Martin, Carlos Pardo-Pastor, Gisli Jenkins, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top